Mirus Advises TheraCell on its Sale to Isto Biologics
Mirus Capital Advisors is pleased to announce that it served as the exclusive financial advisor to TheraCell, Inc., a California based orthobiologics company, in its sale to Isto Biologics. Isto Biologics is a portfolio company of Thompson Street Capital Partners (TSCP). The terms of the deal were not disclosed.
The acquisition will strengthen Isto’s focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics and sports medicine.
“We are thrilled to add TheraCell’s unmatched technology to our market leading biologics portfolio,” said Don Brown, CEO of Isto Biologics. “TheraCell has excelled in developing advanced bone integrating, anchoring and bridging technologies for spinal repair for over a decade.”
The acquisition will expand Isto Biologics’ growing portfolio of orthopedic grafts and introduce TheraCell’s proprietary and patented TheraFuze DBF® technology that will become part of Isto Biologics’ Influx™ line.
“Isto is the leader in allo-derived spine solutions. They have an incredible patient-centric, outcomes-focused commercial and clinical team that will rapidly accelerate the surgical adoption of the technology that we’ve always been passionate about,” added Bradley Patt, CEO of TheraCell.
“Both Isto Biologics and TheraCell have achieved success in developing and introducing innovative, first-of-their-kind product offerings to help patients heal faster,” said Harry Holiday, Chairman of the Board at Isto Biologics and Managing Director at TSCP. “Adding TheraCell’s product portfolio to Isto’s top-tier sales team will add tremendous value to TheraCell’s place in the market. We anticipate an unparalleled synergy by combining these two great organizations.”
About TheraCell, Inc.
TheraCell is focused on the development of advanced technologies for bone and soft tissue repair and is the inventor of the next-generation, TheraFuze DBF ® demineralized bone fiber technology. Founded in 2008, the firm is headquartered in Los Angeles, CA and maintains offices and laboratories in Littleton, MA.
About Isto Biologics
Isto Biologics is a leading biologic and cellular therapy company in the orthopedic space. Hopkinton, MA-based Isto Biologics is focused on Helping Patients Heal Faster ™ through innovative solutions for bone regeneration and cell-based therapies. The company’s flagship product offerings include the market-leading Magellan ® Autologous Platelet Separator, and bone-growth products including InQu ® Bone Graft Extender & Substitute, and the Influx™ product family. For more information, visit istobiologics.com
About Thompson Street Capital Partners
Thompson Street Capital Partners ( tscp.com ) is a St. Louis-based private equity firm focused on investing in founder-led middle market businesses in the Life Sciences & Healthcare, Software & Technology, and Business and Consumer Services and Products sectors. Founded in 2000, the firm has acquired more than 150 companies. TSCP partners with management teams to increase value by accelerating growth, both organically and via acquisitions.
About Mirus Capital Advisors
Successful business owners have turned to Mirus Capital Advisors for more than 30 years to help them realize their ultimate accomplishment – the sale of their business. As a mid-market investment bank focused on mergers and acquisitions, Mirus drives successful deals for companies in the industrial, consumer products, healthcare, business services, and technology sectors. Mirus has proven time and again that its deep industry expertise, focus on relationships, thorough preparation and unwavering commitment to every deal lead to meaningful accomplishments for business owners. For more, visit www.merger.com.Back to Transactions